Joseph Fuisz, Fuisz Tobacco's Managing Member commented: "These study results represent a remarkable advance for smokeless tobacco.
, continued: "It is important to understand that the Fuisz Tobacco strip's super bioavailability is used to lower the amount of tobacco contained in our smokeless product, and not to develop ever-higher nicotine plasma concentrations.
Fuisz Tobacco's managing partner, Joseph Fuisz, is a corporate lawyer and is a named inventor on over forty thin film drug delivery patents issued and pending.
Mr. Fuisz previously served as Senior Vice President for Business Development of MonoSol Rx (www.monosolrx.com).
He is a graduate of Yale College and the Columbia Law School.